Clinical trials
Alzheimer Disease or Associated Disorder clinical trials
Below are recruiting alzheimer disease or associated disorder clinical trials, each written for real people, not researchers. We’re tracking 1,830 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06570798RecruitingPhase 2
Testing Two Drugs for Lupus and Rheumatoid Arthritis
This trial tests two study drugs, inebilizumab and blinatumomab, for people with lupus (SLE) or rheumatoid arthritis (RA) that hasn't gotten better with standard treatments. It focuses on those with active disease, especially lupus-related kidney problems.
Scottsdale, ArizonaAges 18–75 - NCT06820723RecruitingPhase 2
Testing a single dose of CYB003 for depression and anxiety
This trial tests a single dose of an investigational drug (CYB003) in people with depression and anxiety who haven't gotten enough help from their current antidepressant. You would take a psilocybin-like medication and be monitored for how it affects your mood and anxiety.
Columbus, OhioAges 21–65 - NCT07428538RecruitingPhase 3
Testing larsucosterol for severe alcohol-related hepatitis
This trial tests a new medicine called larsucosterol to see if it helps people with severe alcohol-related hepatitis (liver inflammation from heavy drinking). If you qualify, the study will monitor your safety and recovery over 90 days.
Birmingham, AlabamaAges 18 years+ - NCT07549698RecruitingPhase 1/Phase 2
CRISPR Gene Therapy for Immune Blood Disorders
This trial tests CTX112, a new CRISPR gene therapy that modifies your immune cells to treat severe immune thrombocytopenic purpura (ITP) or warm autoimmune hemolytic anemia (WAIHA) that hasn't responded to standard treatments. The goal is to see if it's safe and can help your body stop attacking its own blood cells.
Rochester, MinnesotaAges 18 years+ - NCT06092333RecruitingPhase 2
New combo therapy for chronic hepatitis B
This trial tests a new medicine (VIR-2218) combined with a standard injection (peginterferon) to see if it can better control chronic hepatitis B. It may be an option if your virus levels are low and you haven't had recent treatment.
Bethesda, MarylandAges 18–65 - NCT07714512RecruitingPhase 1/Phase 2
Anti-CD38 antibody for severe aplastic anemia not helped by other treatments
This study tests a new antibody drug (anti-CD38) for people with severe aplastic anemia that has not responded to or has come back after standard treatments. The goal is to see if this drug can help improve blood counts when other options have failed.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07712211Recruiting
Pain Catastrophizing and Nausea After Gallbladder Surgery
This study looks at how a person's tendency to focus on and feel overwhelmed by pain (called 'pain catastrophizing') might affect nausea and vomiting after gallbladder surgery. If you are scheduled for keyhole gallbladder removal, you may help doctors better predict and prevent post-surgery nausea.
TrabzonAges 18–65 - NCT06049680RecruitingPhase 4
Safety study of SMOFlipid for patients needing IV nutrition
This trial tests if SMOFlipid, a special lipid emulsion given through an IV, is safe for children and adults who need most of their nutrition from IV for at least 8 weeks. It looks for side effects like essential fatty acid deficiency or liver problems.
Atlanta, GeorgiaAges 1 month–17 years - NCT07708246Recruiting
Parent-led social skills program for children with autism
This trial tests whether a parent-led program can help children with autism improve social understanding. If you join, you will learn to use play-based activities at home with your child, with support from a clinician.
Shanghai, Shanghai MunicipalityAges 4–8 - NCT07707310Recruiting
Exercise to prevent disability after hospital stay
This study tests whether a gentle exercise program while you are in the hospital can help you stay strong and independent after you go home. It is for people aged 75 and older who are admitted for a medical condition.
PamplonaAges 75 years+ - NCT06997965RecruitingPhase 4
Mirikizumab for Crohn's with inflammatory strictures
This study tests a medication called mirikizumab to see if it can help people with Crohn's disease who have narrowing (strictures) in the small intestine caused by inflammation. The goal is to improve symptoms like belly pain after eating and to possibly reduce the narrowing without needing surgery.
Orlando, FloridaAges 18 years+ - NCT03109171Recruiting
Test accuracy using a scope-based feeling test for sleep apnea
This study checks how accurately a special camera/scope test can measure throat sensation in people being evaluated for obstructive sleep apnea (OSA). If the test works well, it may help improve how clinicians understand and assess OSA-related changes.
Bogotá, Bogota D.C.Ages 18 years+ - NCT03158090Recruiting
Study of treatment patterns for acromegaly over time
This study follows people with acromegaly to better understand how treatments are used in real life and how well they work over time. It may help improve future treatment choices by comparing outcomes across different care patterns.
Guangzhou, GuangdongAges 18–75 - NCT03475147Recruiting
Smartphone test for vision problems
This trial is checking how well a smartphone “flicker” vision test works for people who have a scotoma (an area of missing or reduced vision). It may help confirm whether the smartphone test can measure or detect optic-related vision problems.
Iowa City, IowaAges 18–80 - NCT03470246Recruiting
Wearable activity coaching after heart surgery
This study tests a personalized activity program and coaching after heart surgery, using wearable sensors to track movement. It may help you recover more safely and move in a goal-directed way during rehabilitation.
KuopioAges 30–90 - NCT03588975RecruitingPhase 3
MACI transplant for knee cartilage defects in ages 10 to 17
This Phase 3 study tests whether a cartilage repair transplant called MACI (a lab-made cartilage-like tissue) can improve symptoms in young people with knee cartilage damage. It compares a surgery approach chosen for each person, aiming to reduce pain and improve knee function.
Palo Alto, CaliforniaAges 10–17 - NCT03615690Recruiting
Fasting-mimicking diet test for ulcerative colitis
This study tests whether a “fasting-mimicking diet” can improve mild to moderate ulcerative colitis. You would follow the study diet plan and be monitored to see if symptoms and disease activity change.
Palo Alto, CaliforniaAges 18–70 - NCT03713424RecruitingPhase 2
Brain scan study of an antibiotic for drug addiction
This study uses an MRI brain scan to see how taking clavulanic acid affects brain activity related to drug addiction. It may help researchers understand whether this medicine could change how addiction-related cues affect the brain.
Columbia, MissouriAges 18–65 - NCT03801434RecruitingPhase 2
Ruxolitinib for people with certain eosinophil overgrowth diseases
This trial studies ruxolitinib to treat illnesses where the body makes too many eosinophils (a type of white blood cell) and symptoms or organ damage happen. It may help shrink disease activity when steroids are not enough, cannot be tolerated, or the illness comes back.
Palo Alto, CaliforniaAges 18 years+ - NCT03807310Recruiting
Vitamin and fatty-acid supplement study for COPD recovery
This trial tests whether a targeted supplement (vitamins D and fatty acids) can help people with COPD. It’s meant for people who are medically stable and not currently dealing with a recent COPD flare-up.
Maastricht, LimburgAges 18 years+ - NCT03821129Recruiting
Reduce recurrent stroke with a PFO closure device and antiplatelet pills
This study looks at whether closing a heart opening called a patent foramen ovale (PFO) with a special septal occluder, along with antiplatelet medications, can lower the risk of another stroke. It is for people who recently had a stroke thought to be caused by a clot that traveled from the heart but without another clear source.
Tucson, ArizonaAges 18–70 - NCT03862859RecruitingPhase 4
Warfarin safety for people with atrial fibrillation on dialysis
This trial studies whether the blood thinner warfarin is safe and effective for preventing stroke and blood clots in people who have atrial fibrillation and need long-term dialysis. It may help your care team better balance clot prevention against bleeding risk.
Herlev, HerlevAges 18 years+ - NCT03872102Recruiting
Brain imaging study to track Parkinson-related disease changes
This study uses brain scans and clinical check-ins to better diagnose and predict how Parkinson-related conditions may progress over time. It may help researchers find markers that explain why symptoms change, and could improve future care.
Dallas, TexasAges Any age - NCT03878121RecruitingPhase 1
Ad4-HIV vaccine study for healthy adults and partners
This Phase 1 study tests whether an experimental HIV vaccine (made from a harmless viral vector) is safe and helps the body build immune defenses. It includes healthy volunteers and, in some groups, their close partners, with careful screening and follow-up visits.
Bethesda, MarylandAges 18–65
Hear when a new Alzheimer Disease or Associated Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for alzheimer disease or associated disorder?
- Yes. Clin2 currently lists 1,830 recruiting alzheimer disease or associated disorder studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a alzheimer disease or associated disorder trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a alzheimer disease or associated disorder trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.